Portal Vein and Bile Duct Toxicity Following Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC)

被引:1
|
作者
Takahashi, S. [1 ]
Kimura, T. [1 ]
Nishibuchi, I. [1 ]
Takahashi, I. [1 ]
Takeuchi, Y. [1 ]
Doi, Y. [1 ]
Kenjo, M. [1 ]
Kaneyasu, Y. [1 ]
Murakami, Y. [1 ]
Nagata, Y. [1 ]
机构
[1] Hiroshima Univ, Dept Radiat Oncol, Hiroshima, Japan
关键词
D O I
10.1016/j.ijrobp.2012.07.870
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S331 / S331
页数:1
相关论文
共 50 条
  • [1] Outcomes of Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC)
    Waller, J. G.
    Naugler, W.
    Zaman, A.
    Orloff, S.
    Billingsley, K.
    Vaccaro, G.
    Kolbeck, K.
    Kaufman, J.
    Tanyi, J.
    Fuss, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S326 - S327
  • [2] Case reports of portal vein thrombosis and bile duct stenosis after stereotactic body radiation therapy for hepatocellular carcinoma
    Takahashi, Shigeo
    Kimura, Tomoki
    Kenjo, Masahiro
    Nishibuchi, Ikuno
    Takahashi, Ippei
    Takeuchi, Yuki
    Doi, Yoshiko
    Kaneyasu, Yuko
    Murakami, Yuji
    Honda, Yoji
    Aikata, Hiroshi
    Chayama, Kazuaki
    Nagata, Yasushi
    HEPATOLOGY RESEARCH, 2014, 44 (10) : E273 - E278
  • [3] The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
    Kimura, Tomoki
    Fujiwara, Toshiki
    Kameoka, Tsubasa
    Adachi, Yoshinori
    Kariya, Shinji
    CANCERS, 2022, 14 (18)
  • [4] Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma
    Thomas H.R.
    Feng M.
    Current Hepatology Reports, 2021, 20 (1) : 12 - 22
  • [5] STEREOTACTIC BODY RADIATION THERAPY ON PORTAL VEIN TUMOR THROMBUS OF HEPATOCELLULAR CARCINOMA
    Kwon, J. H.
    Bae, S. H.
    Rha, S. E.
    Jung, S. E.
    Choi, B. O.
    Jang, H. S.
    Jang, J. W.
    Choi, J. Y.
    Yoon, S. K.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S93 - S93
  • [6] Stereotactic body radiation therapy (SBRT) as a bridge-to-liver transplantation (LT) for hepatocellular carcinoma (HCC)
    Tabchouri, N.
    Doyen, A.
    Crespin, M.
    El Amrani, M.
    Ningarhari, M.
    Mirabel, X.
    D'Alteroche, L.
    Chapet, S.
    Bucur, P.
    Salame, E.
    TRANSPLANTATION, 2022, 106 (8S) : 162 - 163
  • [7] Comparison Between IMAT And IMRT Planning For Stereotactic Body Radiation Therapy (SBRT) Of Hepatocellular Carcinoma (HCC)
    Simeonova, A. O.
    Rhodes, S.
    Stieler, F.
    Tanyi, J. A.
    Fuss, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S356 - S357
  • [8] Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
    Velec, Michael
    Haddad, Carol R.
    Craig, Tim
    Wang, Lisa
    Lindsay, Patricia
    Brierley, James
    Brade, Anthony
    Ringash, Jolie
    Wong, Rebecca
    Kim, John
    Dawson, Laura A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (05): : 939 - 946
  • [9] Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
    Velec, M.
    Craig, T.
    Wang, L.
    Russo, M.
    Lindsay, P. E.
    Haddad, C. R.
    Kim, J. J.
    Dawson, L. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E175 - E175
  • [10] Outcomes of Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma (HCC)
    Bujold, A.
    Massey, C.
    Kim, J. J.
    Brierley, J. D.
    Cho, C.
    Wong, R.
    Dinniwell, R. E.
    Knox, J. J.
    Sherman, M.
    Dawson, L. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S70 - S71